Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Original Research

Published on 18 Oct 2022

Cost-effectiveness of edaravone dexborneol versus edaravone for the treatment of acute ischemic stroke in China: Based on the TASTE study

in Drugs Outcomes Research and Policies

Fenghao Shi
Zixuan He
Lin Wang
Hang Su
Sheng Han

Frontiers in Pharmacology

doi 10.3389/fphar.2022.938239

4,211 views
11 citations

Original Research

Published on 17 Oct 2022

Patient-reported outcomes labeling for oncology drugs: Multidisciplinary perspectives on current status and future directions

in Drugs Outcomes Research and Policies

David Cella
Chieh-I Chen
Ruben G. W. Quek
Ainhoa Uribarren
Matthew Reaney
Vera Mastey
Deborah Collyar
Olivier Chassany

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1031992

6,808 views
7 citations

Original Research

Published on 17 Oct 2022

An analysis of the essential medicines policy in primary care: Findings from MedMinas project

in Drugs Outcomes Research and Policies

Tatiana Chama Borges Luz
Noemia Urruth Leão Tavares
Isabela Cristina Marques
Ana Karine Sarvel de Castro
Betania Barros Cota

Frontiers in Pharmacology

doi 10.3389/fphar.2022.953329

2,728 views
2 citations

Review

Published on 14 Oct 2022

The pathogenesis, diagnosis, prevention, and treatment of CAR-T cell therapy-related adverse reactions

in Drugs Outcomes Research and Policies

Yanping Li
Yue Ming
Ruoqiu Fu
Chen Li
Yuanlin Wu
Tingting Jiang
Ziwei Li
Rui Ni
Li Li
Hui Su

Frontiers in Pharmacology

doi 10.3389/fphar.2022.950923

14,249 views
31 citations

Original Research

Published on 14 Oct 2022

Economic burden of opioid misuse focused on direct medical costs

in Drugs Outcomes Research and Policies

Miryoung Kim
Siin Kim
Hae Sun Suh

Frontiers in Pharmacology

doi 10.3389/fphar.2022.928890

2,808 views
1 citation

Systematic Review

Published on 14 Oct 2022

Efficacy and safety of tirzepatide in patients with type 2 diabetes mellitus: A bayesian network meta-analysis

in Drugs Outcomes Research and Policies

Ruifang Guan
Qing Yang
Xiaolei Yang
Wandi Du
Xuening Li
Guo Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2022.998816

9,108 views
16 citations

Original Research

Published on 13 Oct 2022

Comparison of different methods to assess tacrolimus concentration intra-patient variability as potential marker of medication non-adherence

in Drugs Outcomes Research and Policies

Barbora Kostalova
Katerina Mala-Ladova
Sylvie Dusilova Sulkova
Kris Denhaerynck
Sabina De Geest
Josef Maly

Frontiers in Pharmacology

doi 10.3389/fphar.2022.973564

2,857 views
12 citations

Original Research

Published on 11 Oct 2022

Incidence, characteristics and risk factors of hypofibrinogenemia associated with tigecycline: A multicenter retrospective study in China

in Drugs Outcomes Research and Policies

Bing Leng
Chengwu Shen
Tiantian Gao
Kai Zhao
Xuemei Zhao
Yujin Guo
Jiyong Wu
Jing Yang
Wei Fang
Jicheng Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.943674

3,227 views
14 citations

Original Research

Published on 10 Oct 2022

New insight into the analgesic recipe: A cohort study based on smart patient-controlled analgesia pumps records

in Drugs Outcomes Research and Policies

Yiyan Song
Qiulan He
Wenzhong Huang
Lu Yang
Shaopeng Zhou
Xiaoyu Xiao
Zhongxing Wang
Wenqi Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.988070

3,087 views
9 citations

Original Research

Published on 10 Oct 2022

Administration of recombinant human thrombopoietin is associated with alleviated thrombocytopenia in adult intensive care unit patients with pneumonia: A single-center retrospective study

in Drugs Outcomes Research and Policies

Bailiang Chen
Jiabin Xuan
Feng Wu
Nengxian Shi
Jianwei Dai
Shumin Cai
Shengli An
Qiaobing Huang
Xiaoling Huang
Zhongqing Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1007719

2,965 views
2 citations

Brief Research Report

Published on 10 Oct 2022

Predictors of inappropriate antimicrobial prescription: Eight-year point prevalence surveys experience in a third level hospital in Spain

in Drugs Outcomes Research and Policies

María Núñez-Núñez
Salvador Perez-Galera
José Antonio Girón-Ortega
Santiago Sandoval Fernández-Del-Castillo
Margarita Beltrán-García
Marina De Cueto
Ana Isabel Suárez-Barrenechea
Zaira R. Palacios-Baena
Pedro Terol-Barrero
Fernando Oltra-Hostalet

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1018158

2,926 views
3 citations

Original Research

Published on 10 Oct 2022

Therapeutic drug monitoring practices of anti-infectives: An Asia-wide cross-sectional survey

in Drugs Outcomes Research and Policies

Jingjing Hou
Debbie Marriott
Dario Cattaneo
Sophie Stocker
Jana Stojanova
Jan-Willem Alffenaar
Chenlin Xiao
Yichang Zhao
Hui Gong
Miao Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2022.992354

3,910 views
6 citations

Original Research

Published on 07 Oct 2022

Healthcare professionals’ knowledge, attitude and practice towards National Centralized Drug Procurement policy in central China: A cross-sectional study

in Drugs Outcomes Research and Policies

Anqi Huang
Xuanxuan Wang
Yun Tao
Likai Lin
Hong Cheng

Frontiers in Pharmacology

doi 10.3389/fphar.2022.996824

4,538 views
7 citations

Original Research

Published on 07 Oct 2022

Rivaroxaban in heart failure patients with left ventricular thrombus: A retrospective study

in Drugs Outcomes Research and Policies

Qian Zhang
Zhongfan Zhang
Haikuo Zheng
Ming Qu
Shouping Li
Ping Yang
Daoyuan Si
Wenqi Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1008031

3,815 views
11 citations

Editorial

Published on 06 Oct 2022

Editorial: Pharmacometrics—tools to assure optimal medicine use in low- and middle-income countries

in Drugs Outcomes Research and Policies

Ahmed A. Abulfathi
Linda A. Chaba
Elin M. Svensson
Goonaseelan C. Pillai
Bernd Rosenkranz

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1034807

1,159 views
2 citations

Clinical Trial

Published on 06 Oct 2022

The Effects of sodium bicarbonate Ringer’s solution on acute kidney injury and the clinical outcomes after liver transplantation: A randomized controlled trial

in Drugs Outcomes Research and Policies

Hao Wu
Gaige Meng
Chunlong Zuo
Jiang Wang
Shiyun Jin
Lijian Chen
Ye Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.982472

3,716 views
11 citations